CVS Caremark: Medicaid Paid First, Then Asked for Its Money Back

Whistleblower Justice Network

Caremark agreed to pay $4.25 million in the CVS Caremark Medicaid reimbursement settlement over allegations that its Quantum Leap system canceled claims for prescription costs owed by private health plans. A former quality assurance representative brought the case. For a pharmacy benefit manager employee who knows the reimbursement rules, the allegation is familiar territory: a claim enters the system, a rule determines its fate, and Medicaid is left carrying a bill the private plan should have paid.

A separate False Claims Act settlement followed, involving RxCLAIM, a different computer platform and a different former employee. Later, CVS disclosed reimbursement conduct under an existing Corporate Integrity Agreement and reached an administrative settlement with the Department of Health and Human Services Office of Inspector General. Cancellation, deductions, rejection: the allegations describe different ways of leaving the public program with the cost.

Why the Private Plan Owed Medicaid

Caremark administered prescription drug benefits for private health care plans whose members also had Medicaid coverage. As the Justice Department explained the reimbursement obligation, the private insurer had to bear the prescription cost. When Medicaid paid that claim in error, it could seek reimbursement from the insurer or its pharmacy benefit manager.

The releases call these beneficiaries dual eligibles. Here, that means people covered by Medicaid and a Caremark-administered private plan.

In these cases, Caremark LLC was the pharmacy benefit manager handling the private plans’ reimbursement obligations. CVS Caremark Corporation operated Caremark.

Medicaid pays the prescription bill, asks the responsible private payer to reimburse it, and allegedly loses the money through the payer’s own claims system. The public program becomes the backstop for a private plan’s unpaid obligation.

Quantum Leap and the Canceled Reimbursement Claims

The government alleged that Caremark used Quantum Leap to cancel reimbursement claims submitted by Medicaid. Its December 2, 2013 announcement described a knowing failure to reimburse the program for prescription costs that Caremark-administered private plans should have borne.

Medicaid had already paid for the prescription. The alleged cancellation occurred when the program sought its money back. An employee who understands how those reimbursement claims are processed can see a part of the payment chain that the prescription itself would never explain.

The former quality assurance representative filed a False Claims Act whistleblower case, and the United States joined it. The U.S. Attorney’s Office for the Western District of Texas, the Justice Department’s Civil Division, Commercial Litigation Branch, and the attorneys general for Arkansas, California and Louisiana jointly litigated the case.

RxCLAIM and the Copayments Deducted From Medicaid’s Money

RxCLAIM allegedly underpaid Medicaid by improperly deducting copayments or deductibles when calculating certain reimbursements. In the September 26, 2014 settlement, Caremark agreed to pay $6 million to the United States over that alleged failure to reimburse the program fully.

The claim could produce a payment and still leave Medicaid short. That is the difference from the Quantum Leap allegations: canceling the request eliminated reimbursement, while the RxCLAIM calculation allegedly reduced the amount due. Looking only for rejected claims would miss the second mechanism. For the insider, the calculation behind the payment matters as much as the status attached to the claim.

We would examine the amount Medicaid sought, the deduction applied and the reimbursement calculated for the same claim. A payment total without its underlying calculation leaves the central question unanswered.

A different former Caremark employee brought this qui tam case, and the United States joined it too. The Justice Department’s Civil Division, the U.S. Attorney’s Office for the Western District of Texas and HHS-OIG jointly handled the case. The employee’s whistleblower reward was set at $1.02 million.

The Later Disclosure Came Through an Existing Integrity Agreement

On December 22, 2016, CVS Health agreed to pay $2 million in a separate administrative resolution under the Civil Monetary Penalties Law. The HHS-OIG notice says CVS disclosed the conduct under its Corporate Integrity Agreement.

OIG alleged that CVS, acting as pharmacy benefit manager for its clients, improperly rejected, denied or reduced pharmacy payments on claims by state Medicaid, Veterans Affairs, Indian Health Services and Military Health System programs. The affected beneficiaries also qualified for benefits under CVS-administered programs. This resolution reached several public healthcare programs, with Medicaid among them.

The earlier cases began with employees’ False Claims Act lawsuits. This matter reached OIG through CVS’s disclosure under an agreement already in force. Different resolutions, the same alleged shortfall for Medicaid. The separate CVS ranitidine case concerned alleged drug switching to increase Medicaid payments to the pharmacy, while Quantum Leap and RxCLAIM concerned allegedly canceled or reduced reimbursements back to Medicaid after it had paid.

What a Claims-System Employee Can Explain

A claims-system employee can connect the reimbursement result to the rule that produced it. In these cases, the useful distinction is between a canceled claim, a reduced payment and the coverage that made the private plan responsible. Our review would connect those decisions with the employee’s knowledge of how the system was meant to work and what people inside the business understood it was doing.

The 1999 report Controlling Fraud and Abuse in Medicaid: Innovations and Obstacles, from seminars sponsored by the Health Care Financing Administration, explains why claims analysis needs more than a ledger of successful payments. In discussing what claims history databases should contain, it says:

They should include claims denied as well as claims paid, because claims denied provide a rich source of information about efforts by fraud perpetrators to test, and then game, a payment system.

Controlling Fraud and Abuse in Medicaid: Innovations and Obstacles, Health Care Financing Administration seminar report, 1999

The report discusses detecting attempts to game payment systems. Applied to these reimbursement allegations, its broader view of claims data is useful: we would want the canceled requests alongside the reimbursements that went through. For a deduction dispute, we would also want the calculation that turned the amount requested into the amount paid.

The report described states introducing pharmacy monitoring, historical claims analysis and fraud-focused edits within claims systems. It also emphasized insiders’ ability to explain company policy and practice when discussing fraud involving health plans. Those observations give a practical reason to value the employee who understands a payment rule, its intended result and its actual output.

For a pharmacy benefit manager reimbursement case, we would examine payer and eligibility information, claim status histories, deduction fields and the instructions behind the calculation. Quality assurance findings and internal explanations of a rule could connect the numbers to the decisions behind them. A system can faithfully apply the rule it was given. The question is why that rule left Medicaid with the bill.

Can You Get Paid for Reporting Medicaid Fraud?

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. Both Caremark reimbursement lawsuits began with former employees, and both settlement announcements provided for whistleblower rewards.

You Know Why the Claim Came Back Short

If you know the rule behind canceled Medicaid claims or deductions that left the program unpaid, speak to one of our whistleblower experts about how the claim came back short. We work with you to turn that operational knowledge into your strongest Medicaid whistleblower case and bring in Medicaid fraud whistleblower lawyers who understand PBM claims systems. You bring the view from inside the process, and we bring the judgment and partnership to pursue it with you.

WHISTLEBLOWER JUSTICE NETWORK CAN HELP YOU
Make a difference.
Whistleblower Justice NetworkReport Fraud
100% CONFIDENTIALFREE CONSULTATION24 / 7 / 365